Opyl (OPL) Stock Price, News & Analysis

Company Overview

Opyl Limited develops digital tools that enhance healthcare experience for patients in Australia. The company also delivers deep market insights from social media data and enhance clinical research process. It offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in St Kilda, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $3.28 million
• P/E Ratio: N/A
• Dividend Yield: 10.83%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: ASX:OPL
• CIK: N/A
• Web: www.opyl.ai
• Phone: 61 3 9923 1222
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-3,130,000.00
• Net Margins: -787.24%
• Pretax Margin: N/A
• Return on Equity: 4,069.01%
• Return on Assets: -300.55%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.77
• Quick Ratio: 1.34

Sales & Book Value

• Annual Sales: $902,413.00
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.00 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 170,720,000
• Free Float: N/A
• Market Cap: $3.28 million
• Optionable: Not Optionable
• Beta: 1.89